Top

Reactions Weekly

Published in:

01-10-2022 | Case report

Canakinumab

Infection: 2 case reports

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kuemmerle-Deschner JB, et al. Long-term safety and efficacy of canakinumab in cryopyrinassociated periodic syndromes (CAPS) - 36-month data from the reliance registry. Pediatric Rheumatology 20 (Suppl. 2): abstr. P144, Sep 2022. Available from: URL: http://doi.org/10.1186/s12969-022-00729-z [abstract]

Title: Canakinumab
Infection: 2 case reports
Publication date: 01-10-2022
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-26411-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Canakinumab

Infection: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Naloxone/vancomycin

Immunosuppressants

Antineoplastics

Lopinavir/ritonavir

Multiple drugs

Posaconazole